×
About 1,030 results

ALLMedicine™ Cardioembolic Stroke Center

Research & Reviews  375 results

Pharmacological Difference Between Platelet Aggregations in Cardioembolic Stroke Patien...
https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106520
Journal of Stroke and Cerebrovascular Diseases : the Offi... Nakazaki M, Oka S et. al.

May 7th, 2022 - Background Selecting the appropriate direct oral anticoagulants (DOACs) for embolic ischemic stroke patients, especially on concurrent antiplatelet therapy, is important. However, a limited number of studies have reported on the pharmacological di...

Timing of Direct Oral Anticoagulants for Hemorrhagic Transformation After Endovascular ...
https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106507
Journal of Stroke and Cerebrovascular Diseases : the Offi... Nishimoto T, Oka F et. al.

May 2nd, 2022 - The purpose of this study is to investigate the relationship between the timing of starting direct oral anticoagulants (DOACs) and subsequent clinical outcomes in patients with hemorrhagic transformation (HT) after endovascular treatment (EVT). Th...

Translational Immunodiagnostics in Stroke (TrImS)
https://clinicaltrials.gov/ct2/show/NCT05300997

Apr 29th, 2022 - Introduction Stroke is a leading cause of overall mortality, morbidity and disability worldwide. In 2010 it was the second leading cause of death whilst in 2019 it ranked third overall for disability adjusted life years (DALYs) and second for thos...

Genetic associations of adult height with risk of cardioembolic and other subtypes of i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032370
PLoS Medicine; Linden AB, Clarke R et. al.

Apr 23rd, 2022 - Taller adult height is associated with lower risks of ischemic heart disease in mendelian randomization (MR) studies, but little is known about the causal relevance of height for different subtypes of ischemic stroke. The present study examined th...

Left Atrial Thrombus-Are All Atria and Appendages Equal?
https://doi.org/10.1016/j.iccl.2021.11.005
Interventional Cardiology Clinics; Cresti A, Camara O

Apr 2nd, 2022 - Although the left atrial appendage (LAA) seems useless, it has several critical functions that are not fully known yet, such as the causes for being the main origin of cardioembolic stroke. Difficulties arise due to the extreme range of LAA morpho...

see more →

Clinicaltrials.gov  5 results

Translational Immunodiagnostics in Stroke (TrImS)
https://clinicaltrials.gov/ct2/show/NCT05300997

Apr 29th, 2022 - Introduction Stroke is a leading cause of overall mortality, morbidity and disability worldwide. In 2010 it was the second leading cause of death whilst in 2019 it ranked third overall for disability adjusted life years (DALYs) and second for thos...

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms
https://clinicaltrials.gov/ct2/show/NCT04192916

Feb 21st, 2021 - Patients with myeloproliferative neoplasms (MPN) are predisposed to have an increased thrombotic and hemorrhagic risk and, in this context, the use of newly approved direct oral anticoagulants (DOACs) may have improved bleeding risk compared to wa...

Brain MRI in Stroke Patients With Intracardiac Thrombus
https://clinicaltrials.gov/ct2/show/NCT04456309

Nov 20th, 2020 - Acute infarction patterns have been described in cardioembolic stroke, mainly with atrial fibrillation (AF) or patent foramen ovale. We aimed to analyse acute infarction MRI characteristics in stroke patients with intracardiac thrombus (ICT) compa...

Canadian Pradaxa Acute Stroke Safety Study
https://clinicaltrials.gov/ct2/show/NCT02415855

Jun 19th, 2020 - Study Aim and Design: The primary aim of the CPASS registry is to demonstrate the safety of early anticoagulation with dabigatran following cardioembolic stroke. CPASS is a prospective open label single arm observational study. Safety will be esta...

RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke
https://clinicaltrials.gov/ct2/show/NCT02129920

May 2nd, 2014 - Early recurrence of cardioembolic stroke in patients with atrial fibrillation is common, reaching approximately 6% within 30 days after initial stroke. Therefore, it is preferable to provide early anticoagulation for cardioembolic stroke. However,...

see more →

News  32 results

Ticagrelor Steps It Up for Stroke Patients With Impaired Clopidogrel Metabolism
https://www.medpagetoday.com/cardiology/strokes/95304

Oct 28th, 2021 - Stroke survivors carrying CYP2C19 loss-of-function alleles had better secondary prevention when taking ticagrelor (Brilinta) versus clopidogrel (Plavix) as an add-on to aspirin, according to the Chinese CHANCE-2 trial. Subsequent ischemic or hemor...

Intracranial Atherosclerosis Finding on MRA Linked to Stroke
https://www.medscape.com/viewarticle/955993

Aug 4th, 2021 - An incidental diagnosis of intracranial atherosclerotic stenosis in stroke-free individuals should trigger a thorough assessment of vascular health, according to the authors of a study identifying risk factors and vascular event risk in asymptomat...

Small Complicated Carotid Plaques May Be Culprit in Some Strokes
https://www.medscape.com/viewarticle/940555

Nov 6th, 2020 - The presence of certain complicating features on plaques in the carotid artery are an under-recognized cause of ischemic stroke, a new study suggests. The CAPIAS (Carotid Plaque Imaging in Acute Stroke) study showed that complicated nonstenosing c...

Microbleeds Shouldn't Influence Anticoagulation After Stroke
https://www.staging.medscape.com/viewarticle/939630

Oct 22nd, 2020 - The presence of microbleeds in the brain should not affect the decision to prescribe anticoagulation to patients after an ischemic stroke, new data suggest. The new results come from a prespecified substudy of the NAVIGATE-ESUS trial, which compar...

Microbleeds Shouldn't Influence Anticoagulation After Stroke
https://www.medscape.com/viewarticle/939630

Oct 22nd, 2020 - The presence of microbleeds in the brain should not affect the decision to prescribe anticoagulation to patients after an ischemic stroke, new data suggest. The new results come from a prespecified substudy of the NAVIGATE-ESUS trial, which compar...

see more →